神经重症患者肠内喂养护理专家共识

2022-02-10 中华护理学会重症护理专业委员会 中华护理杂志

形成神经重症患者肠内喂养护理专家共识,推动护士规范、安全、有效地实施肠内喂养,满足患者营养需求。方法检索、评价和汇总神经重症患者肠内喂养护理证据,提取相关的推荐意见,形成共识初稿,通过2轮德尔菲专家函

中文标题:

神经重症患者肠内喂养护理专家共识

发布日期:

2022-02-10

简要介绍:

形成神经重症患者肠内喂养护理专家共识,推动护士规范、安全、有效地实施肠内喂养,满足患者营养需求。方法检索、评价和汇总神经重症患者肠内喂养护理证据,提取相关的推荐意见,形成共识初稿,通过2轮德尔菲专家函询和专家论证会,根据专家建议进行分析、修改及完善,形成共识终稿。结果函询专家积极系数为100%,专家判断系数为0.93,熟悉程度为0.88,权威系数为0.91。肯德尔和谐系数为0.256~0.278,具有统计学意义(P<0.05)。最终形成的共识内容包括神经重症患者肠内喂养护理评估、喂养方式的选择、营养液输注、并发症的识别与护理、停止管饲喂养指标5个方面。结论该共识实用性较强,可为神经重症患者肠内喂养临床护理实践和质量控制提供指导依据。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=神经重症患者肠内喂养护理专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=8590b1c0023e3275, title=神经重症患者肠内喂养护理专家共识, enTitle=, guiderFrom=中华护理杂志, authorId=0, author=, summary=形成神经重症患者肠内喂养护理专家共识,推动护士规范、安全、有效地实施肠内喂养,满足患者营养需求。方法检索、评价和汇总神经重症患者肠内喂养护理证据,提取相关的推荐意见,形成共识初稿,通过2轮德尔菲专家函, cover=https://img.medsci.cn/202235/1646490766385_5579292.png, journalId=0, articlesId=null, associationId=2491, associationName=中华护理学会重症护理专业委员会, associationIntro=中华护理学会重症护理专业委员会, copyright=0, guiderPublishedTime=Thu Feb 10 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">形成神经重症患者肠内喂养护理专家共识,推动护士规范、安全、有效地实施肠内喂养,满足患者营养需求。方法检索、评价和汇总神经重症患者肠内喂养护理证据,提取相关的推荐意见,形成共识初稿,通过2轮德尔菲专家函询和专家论证会,根据专家建议进行分析、修改及完善,形成共识终稿。结果函询专家积极系数为100%,专家判断系数为0.93,熟悉程度为0.88,权威系数为0.91。肯德尔和谐系数为0.256~0.278,具有统计学意义(P&lt;0.05)。最终形成的共识内容包括神经重症患者肠内喂养护理评估、喂养方式的选择、营养液输注、并发症的识别与护理、停止管饲喂养指标5个方面。结论该共识实用性较强,可为神经重症患者肠内喂养临床护理实践和质量控制提供指导依据。&nbsp;</span></p>, tagList=[TagDto(tagId=61647, tagName=神经重症), TagDto(tagId=95408, tagName=肠内喂养)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=79, categoryName=护理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4881, appHits=354, showAppHits=0, pcHits=851, showPcHits=4526, likes=3, shares=63, comments=8, approvalStatus=1, publishedTime=Sun Mar 06 15:28:00 CST 2022, publishedTimeString=2022-02-10, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Mar 05 22:32:21 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 06:26:00 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=神经重症患者肠内喂养护理专家共识.pdf)])
神经重症患者肠内喂养护理专家共识.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1214454, encodeId=653512144548f, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230508/c2573541a6524ff0944d5799c7cc7568/264cbd4dbc3541b89cf280191fc834d7.jpg, createdBy=29e92023744, createdName=doufangyan, createdTime=Tue Apr 26 12:44:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214446, encodeId=eede1214446a0, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230508/c2573541a6524ff0944d5799c7cc7568/264cbd4dbc3541b89cf280191fc834d7.jpg, createdBy=29e92023744, createdName=doufangyan, createdTime=Tue Apr 26 12:14:39 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208947, encodeId=feb1120894ebf, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e965633837, createdName=ms9000000682899257, createdTime=Wed Apr 06 11:12:29 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205867, encodeId=c856120586e8e, content=有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=656a6571546, createdName=ms8000001761588731, createdTime=Fri Mar 25 15:29:50 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205866, encodeId=a2b9120586636, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=656a6571546, createdName=ms8000001761588731, createdTime=Fri Mar 25 15:29:18 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
    2022-04-26 doufangyan

    很好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1214454, encodeId=653512144548f, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230508/c2573541a6524ff0944d5799c7cc7568/264cbd4dbc3541b89cf280191fc834d7.jpg, createdBy=29e92023744, createdName=doufangyan, createdTime=Tue Apr 26 12:44:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214446, encodeId=eede1214446a0, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230508/c2573541a6524ff0944d5799c7cc7568/264cbd4dbc3541b89cf280191fc834d7.jpg, createdBy=29e92023744, createdName=doufangyan, createdTime=Tue Apr 26 12:14:39 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208947, encodeId=feb1120894ebf, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e965633837, createdName=ms9000000682899257, createdTime=Wed Apr 06 11:12:29 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205867, encodeId=c856120586e8e, content=有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=656a6571546, createdName=ms8000001761588731, createdTime=Fri Mar 25 15:29:50 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205866, encodeId=a2b9120586636, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=656a6571546, createdName=ms8000001761588731, createdTime=Fri Mar 25 15:29:18 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
    2022-04-26 doufangyan

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1214454, encodeId=653512144548f, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230508/c2573541a6524ff0944d5799c7cc7568/264cbd4dbc3541b89cf280191fc834d7.jpg, createdBy=29e92023744, createdName=doufangyan, createdTime=Tue Apr 26 12:44:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214446, encodeId=eede1214446a0, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230508/c2573541a6524ff0944d5799c7cc7568/264cbd4dbc3541b89cf280191fc834d7.jpg, createdBy=29e92023744, createdName=doufangyan, createdTime=Tue Apr 26 12:14:39 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208947, encodeId=feb1120894ebf, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e965633837, createdName=ms9000000682899257, createdTime=Wed Apr 06 11:12:29 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205867, encodeId=c856120586e8e, content=有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=656a6571546, createdName=ms8000001761588731, createdTime=Fri Mar 25 15:29:50 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205866, encodeId=a2b9120586636, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=656a6571546, createdName=ms8000001761588731, createdTime=Fri Mar 25 15:29:18 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
    2022-04-06 ms9000000682899257

    很好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1214454, encodeId=653512144548f, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230508/c2573541a6524ff0944d5799c7cc7568/264cbd4dbc3541b89cf280191fc834d7.jpg, createdBy=29e92023744, createdName=doufangyan, createdTime=Tue Apr 26 12:44:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214446, encodeId=eede1214446a0, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230508/c2573541a6524ff0944d5799c7cc7568/264cbd4dbc3541b89cf280191fc834d7.jpg, createdBy=29e92023744, createdName=doufangyan, createdTime=Tue Apr 26 12:14:39 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208947, encodeId=feb1120894ebf, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e965633837, createdName=ms9000000682899257, createdTime=Wed Apr 06 11:12:29 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205867, encodeId=c856120586e8e, content=有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=656a6571546, createdName=ms8000001761588731, createdTime=Fri Mar 25 15:29:50 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205866, encodeId=a2b9120586636, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=656a6571546, createdName=ms8000001761588731, createdTime=Fri Mar 25 15:29:18 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
    2022-03-25 ms8000001761588731

    有意义

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1214454, encodeId=653512144548f, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230508/c2573541a6524ff0944d5799c7cc7568/264cbd4dbc3541b89cf280191fc834d7.jpg, createdBy=29e92023744, createdName=doufangyan, createdTime=Tue Apr 26 12:44:08 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214446, encodeId=eede1214446a0, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230508/c2573541a6524ff0944d5799c7cc7568/264cbd4dbc3541b89cf280191fc834d7.jpg, createdBy=29e92023744, createdName=doufangyan, createdTime=Tue Apr 26 12:14:39 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1208947, encodeId=feb1120894ebf, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e965633837, createdName=ms9000000682899257, createdTime=Wed Apr 06 11:12:29 CST 2022, time=2022-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205867, encodeId=c856120586e8e, content=有意义, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=656a6571546, createdName=ms8000001761588731, createdTime=Fri Mar 25 15:29:50 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205866, encodeId=a2b9120586636, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=656a6571546, createdName=ms8000001761588731, createdTime=Fri Mar 25 15:29:18 CST 2022, time=2022-03-25, status=1, ipAttribution=)]
    2022-03-25 ms8000001761588731

    很好

    0